Emergence of High-Level Gentamicin Resistance in Streptococcus agalactiae Hypervirulent Serotype IV ST1010 (CC452) Strains by Acquisition of a Novel Integrative and Conjugative Element
Antibiotics · 26.05.2024 · 13 (6) · 491
DOI: 10.3390/antibiotics13060491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 26.05.2024. Verfasst von Roberta Creti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Malattie Infettive, Reparto di Antibiotico-Resistenza e Patogeni Speciali, Istituto Superiore di Sanità, 00161 Rome, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EDCTP, INF-ACT.
Abstract (Originalsprache)
Streptococcus agalactiae (group B streptococci, GBS) is responsible for severe infections in both neonates and adults. Currently, empiric antimicrobial therapy for sepsis and meningitis is the combined use of penicillin and gentamicin due to the enhanced bactericidal activity. However, high-level gentamicin resistance (HLGR) abrogates the synergism. The rate of HLGR was investigated within a dataset of 433 GBS strains collected from cases of invasive disease in both adults and neonates as well as from pregnant carriers. GBS isolates (n = 20, 4.6%) presented with HLGR (gentamicin MIC breakpoint >1024 mg/L) that was differently diffused between strains from adults or neonates (5.2% vs. 2.8%). Notably, 70% of HLGR GBS strains (14 isolates) were serotype IV. Serotype IV HLGR-GBS isolates were susceptible to all antibiotics tested, exhibited the alpha-C/HvgA/PI-2b virulence string, and belonged to sequence type 1010 (clonal complex (CC) 452). The mobile element that harbored the HLGR aac(6′)-aph(2)″ gene is a novel integrative and conjugative element (ICE) about 45 kb long, derived from GBS 515 ICE tRNALys. The clonal expansion of this HLGR hypervirulent serotype IV GBS CC452 sublineage may pose a threat to the management of infections caused by this strain type.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dipartimento di Malattie Infettive, Reparto di Antibiotico-Resistenza e Patogeni Speciali, Istituto Superiore di Sanità, 00161 Rome, Italy.
- Parasites and Microbes Programme, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
- Neonatal Intensive Care Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena and Reggio Emilia, 41125 Modena, Italy.
- Unità di Ricerca di Scienze Batteriologiche Applicate, Facoltà Dipartimentale di Medicina e Chirurgia, Università Campus Bio-Medico, 00128 Rome, Italy.
ORCID-Profile: Roberta Creti, Uzma Basit Khan, Alberto Berardi, Giovanna Alfarone, Giovanni Gherardi
Förderung
- EDCTP
- INF-ACT
Zitieren
APA
Creti, R., Imperi, M., Khan, U. B., Berardi, A., Recchia, S., Alfarone, G., & Gherardi, G. (2024). Emergence of High-Level Gentamicin Resistance in Streptococcus agalactiae Hypervirulent Serotype IV ST1010 (CC452) Strains by Acquisition of a Novel Integrative and Conjugative Element. Antibiotics, 13(6), 491. https://doi.org/10.3390/antibiotics13060491
Vancouver
Creti R, Imperi M, Khan UB, Berardi A, Recchia S, Alfarone G, et al. Emergence of High-Level Gentamicin Resistance in Streptococcus agalactiae Hypervirulent Serotype IV ST1010 (CC452) Strains by Acquisition of a Novel Integrative and Conjugative Element. Antibiotics. 2024;13(6):491. doi:10.3390/antibiotics13060491
BibTeX
@article{Creti2024,
author = {Creti, Roberta and Imperi, Monica and Khan, Uzma Basit and Berardi, Alberto and Recchia, Simona and Alfarone, Giovanna and Gherardi, Giovanni},
title = {Emergence of High-Level Gentamicin Resistance in Streptococcus agalactiae Hypervirulent Serotype IV ST1010 (CC452) Strains by Acquisition of a Novel Integrative and Conjugative Element},
journal = {Antibiotics},
year = {2024},
volume = {13},
number = {6},
pages = {491},
doi = {10.3390/antibiotics13060491}
}
EUVIMED